Amifostine in Treating Young Patients With Newly Diagnosed De Novo Myelodysplastic Syndromes - No Study Results Posted - ClinicalTrials.gov

Skip to Main Content

ClinicalTrials.gov

Home Search Study Topics Glossary


	Full Text View


	Tabular View


	No Study Results Posted


	Related Studies

Amifostine in Treating Young Patients With Newly Diagnosed De Novo Myelodysplastic Syndromes

This study has been completed.

Study NCT00098683 Information provided by National Cancer Institute (NCI)

First Received: December 7, 2004 Last Updated: June 25, 2011 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Study Status:	This study has been completed.
Estimated Study Completion Date:	No date given
Primary Completion Date:	October 2007 (Final data collection date for primary outcome measure)

Publications:

Mathew P, Gerbing R, Alonzo TA, Wallas T, Gong JZ, Jasty R, Jorstad DT, Raimondi SC, Chavez CM, Eisenberg NL, Hirsch B, Gamis A, Smith FO, Arceci RJ. A phase II study of amifostine in children with myelodysplastic syndrome: A report from the Children's Oncology Group study (AAML0121). Pediatr Blood Cancer. 2011 Jun 16; [Epub ahead of print]

Back to top of Main Content